PDE7A Antibodies

Santa Cruz Biotechnology features a diverse variety of PDE7A monoclonal antibodies for investigating phosphodiesterase 7A in biological processes. PDE7A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphodiesterase 7A regulates intracellular levels of cyclic nucleotides, influencing cell proliferation, differentiation, and apoptosis. The involvement of phosphodiesterase 7A in various physiological and pathological processes makes it a significant target for therapeutic interventions in diseases such as cancer and neurodegenerative disorders. Research utilizing PDE7A monoclonal antibodies can reveal important insights into cellular signaling mechanisms. Investigating phosphodiesterase 7A expression and activity patterns helps advance understanding of disease progression and potential treatment strategies. Exploring PDE7A function contributes to knowledge of fundamental biological processes and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful discoveries that advance scientific understanding of phosphodiesterase 7A biology.